Overview

Relieving Chronic Itch: Oral Medication

Status:
Withdrawn
Trial end date:
2018-10-09
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of twice daily dose of INCB39110 in the treatment of itch in adults.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine